The treatment of patients with low tumour burden and/or slow growing disease.
In the evaluation of the wide range of novel therapeutics which have been developed, investigators do not have to be tied to the current paradigm of demonstrating additive efficacy to first line combination therapy. The addition of new agents to FOLFOX regimens has proved a high hurdle at which many...
第一著者: | Maughan, T |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
The response of fast-, medium- and slow-growing chickens to a low protein diet
著者:: Darina Chodová, 等
出版事項: (2021-03-01) -
Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
著者:: Magaly Zappa, 等
出版事項: (2017-02-01) -
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunityResearch in context
著者:: Jiayi Tan, 等
出版事項: (2024-03-01) -
Slow growing of Stieltjes integrals of monotone functions
著者:: M. V. Zabolotskyj, 等
出版事項: (2013-01-01) -
Cassava residues in the diet of slow-growing broilers
著者:: Silvia Silva VIEIRA, 等
出版事項: (2022-09-01)